Annovis Bio
ANVS
ANVS
31 hedge funds and large institutions have $5.67M invested in Annovis Bio in 2024 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 8 increasing their positions, 8 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
43% less call options, than puts
Call options by funds: $8.64M | Put options by funds: $15.2M
61% less capital invested
Capital invested by funds: $14.4M → $5.67M (-$8.73M)
Holders
31
Holding in Top 10
–
Calls
$8.64M
Puts
$15.2M
Top Buyers
| 1 | +$115K | |
| 2 | +$71.4K | |
| 3 | +$58.3K | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$31.4K |
| 5 |
Belvedere Trading
Chicago,
Illinois
|
+$27.5K |
Top Sellers
| 1 | -$864K | |
| 2 | -$864K | |
| 3 | -$430K | |
| 4 |
Cetera Investment Advisers
Schaumburg,
Illinois
|
-$133K |
| 5 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$66.2K |